GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Other Financing

Spectral Medical (TSX:EDT) Other Financing : C$-0.86 Mil (TTM As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Other Financing?

Spectral Medical's Other Financing for the three months ended in Dec. 2024 was C$-0.44 Mil.

Spectral Medical's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.86 Mil.


Spectral Medical Other Financing Historical Data

The historical data trend for Spectral Medical's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Other Financing Chart

Spectral Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 2.28 1.72 1.51 -0.86

Spectral Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 0.40 -0.62 -0.20 -0.44

Spectral Medical Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical Other Financing Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical Business Description

Traded in Other Exchanges
Address
135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Executives
Paul M. Walker Director
John Ernest Nosenzo Director
Chris Seto Senior Officer
William Charles Stevens Director
Kevin Arnold Giese Director
Gualtiero Piero Guido Maria Guadagni Senior Officer
Debra-anne Foster Deemed Insider - 6 Months before becoming Insider
Anthony Phillip Bihl Director

Spectral Medical Headlines